Pasithea Therapeutics - Warrants (11/08/2026) Other Current Assets

As of the most recent data (June 2026), KTTAW shows a other current assets of $2.6B. That compares with $1.4M in the prior-year period — up 181666.4% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, KTTAW's other current assets is now $2.6B (was $1.4M) — a 181666.4% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pasithea Therapeutics - Warrants (11/08/2026) is outperforming or lagging.

Tracking KTTAW's other current assets over time shows whether Pasithea Therapeutics - Warrants (11/08/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $2.6B That compares with $1.4M in the prior-year period — up 181666.4% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has Pasithea Therapeutics - Warrants (11/08/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $2.6B) with ownership activity and broader fundamentals.

Pasithea Therapeutics - Warrants (11/08/2026)'s other current assets is $2.6B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.